These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Possible dapsone-induced peripheral neuropathy in dermatitis herpetiformis. du Vivier A, Fowler T. Proc R Soc Med; 1974 Jun; 67(6 Pt 1):439-40. PubMed ID: 4369028 [No Abstract] [Full Text] [Related]
46. Investigation of the protective effects of the antioxidants ascorbate, cysteine, and dapsone on the phagocyte-mediated oxidative inactivation of human alpha-1-protease inhibitor in vitro. Theron A, Anderson R. Am Rev Respir Dis; 1985 Nov; 132(5):1049-54. PubMed ID: 2998243 [Abstract] [Full Text] [Related]
55. "Sulfoxone (Diasone) sodium for dermatitis herpetiformis" by Cornbleet, December 1951. Commentary: Sulfoxone (Diasone) in the treatment of dermatitis herpetiformis. Katz SI. Arch Dermatol; 1982 Oct; 118(10):805-12. PubMed ID: 6753759 [No Abstract] [Full Text] [Related]
56. The effect of Eglin C on the function of human neutrophils in vitro. Suter S, Chevallier I. Biol Chem Hoppe Seyler; 1988 Jul; 369(7):573-8. PubMed ID: 2852014 [Abstract] [Full Text] [Related]